TScan Therapeutics Announces Exercise of Underwriters'
WALTHAM, Mass., April 24, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the...
Source: globenewswire.com
Sci Capital News Today : Breaking News, Live Updates & Top Stories | Vimarsana
Stay updated with breaking news from Sci Capital. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Top News In Sci Capital Today - Breaking & Trending Today
INmune Bio Inc. Raises Approximately $4.8 Million in Gross Proceeds through Registered Direct Offering with Officers, Employees and Directors Purchasing Approximately 20% of the Offering
Boca Raton, Florida - INmune Bio, Inc. , a clinical-stage immunology company focused on developing treatments that harness the patient's innate immune system to fight disease, today announced today...
Source: marketscreener.com
TScan Therapeutics Announces Closing of Upsized Public Offering
WALTHAM, Mass., April 19, 2024 -- TScan Therapeutics, Inc. , a clinical-stage biopharmaceutical company focused on the development of T cell receptor -engineered T cell therapies for the treatment...
Source: marketscreener.com
TScan Therapeutics Announces Closing of Upsized Public
WALTHAM, Mass., April 19, 2024 (GLOBE NEWSWIRE) -- TScan Therapeutics, Inc. (Nasdaq: TCRX), a clinical-stage biopharmaceutical company focused on the...
Source: globenewswire.com
Larimar Therapeutics Announces Closing of Underwritten Public Offering of Common Stock and Exercise in Full of the Underwriters' Option to Purchase Additional Shares -February 16, 2024 at 04:22 pm EST
BALA CYNWYD, Pa., Feb. 16, 2024 -- Larimar Therapeutics, Inc. , a clinical-stage biotechnology company focused on developing treatments for complex rare diseases, today announced the closing of...
Source: marketscreener.com